Impurose 20mg Tablet contains Rosuvastatin, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia, effectively reducing elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. Impurose 20mg is prescribed as part of a comprehensive management plan including diet, exercise, and lifestyle modifications to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and atherosclerosis in patients with hyperlipidemia or established cardiovascular disease. The recommended dosage should be individualized based on patient response and tolerability, with regular monitoring of lipid profiles and liver function tests advised during therapy. Common adverse effects may include headache, myalgia, abdominal pain, and elevated liver enzymes. Use of Impurose is contraindicated in patients with active liver disease, pregnancy, or known hypersensitivity to rosuvastatin. Caution is warranted when co-administered with other drugs metabolized by the cytochrome P450 system to avoid potential drug interactions.